COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE

Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods. An open non-randomized study was conducted to evaluate direct medical costs (cost of drug, cost of the...

Celý popis

Podrobná bibliografie

Hlavní autoři:	L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Столичная издательская компания 2015-09-01
Edice:	Рациональная фармакотерапия в кардиологии
Témata:	atrial fibrillation cardioversion warfarin dabigatran costs rhythm control.
On-line přístup:	https://www.rpcardio.online/jour/article/view/98
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!